SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-049437
Filing Date
2023-09-22
Accepted
2023-09-22 16:21:36
Documents
13
Period of Report
2023-09-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20230921.htm   iXBRL 8-K 65399
2 EX-3.1 lbph-ex3_1.htm EX-3.1 265377
  Complete submission text file 0000950170-23-049437.txt   508315

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20230921.xsd EX-101.SCH 2495
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20230921_lab.xml EX-101.LAB 18993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20230921_pre.xml EX-101.PRE 12490
7 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20230921_htm.xml XML 5293
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 231271966
SIC: 2834 Pharmaceutical Preparations